The roles of safety and compliance in determining effectiveness of topical therapy for psoriasis.
Topical therapies are the mainstays of treatment for most patients with psoriasis because they relieve symptoms and reduce the size and severity of lesions. The effectiveness of a therapeutic intervention is a function of drug efficacy (determined by randomized clinical trial results) and patient safety and compliance. Alterations in any parameter can have a substantial influence on clinical outcomes. However, topical agents can be associated with unwanted and potentially toxic side effects that make physicians reluctant to prescribe them, and patients intentionally discontinue treatment with these topical agents. To maximize effectiveness and improve patient safety, physicians may prescribe medications in combination, sequential, or rotational therapeutic regimens. This treatment strategy has the potential to improve the overall efficacy and safety of topical therapy; however, the effectiveness of this method may be compromised because the complexity of the therapeutic regimen may decrease patient compliance. Newer topical therapies that have a convenient once-daily dosing schedule are needed and will have important implications for patient compliance.
Stein Gold
Linda
L
Henry Ford Health System, Detroit, Michigan, USA.
Corvari
Linda
L
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D002762:Cholecalciferol / Q000031:analogs & derivatives; D004359:Drug Therapy, Combination; D006801:Humans; D010349:Patient Compliance; D011565:Psoriasis / Q000188:drug therapy*; D012449:Safety; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D002762:Cholecalciferol